This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan;37(1):123-146.
doi: 10.1007/s11011-021-00824-2. Epub 2021 Sep 3.

Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders

Affiliations
Review

Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders

Tooran Nayeri et al. Metab Brain Dis. 2022 Jan.

Abstract

The most common form of the disease caused by Toxoplasma gondii (T. gondii) is latent toxoplasmosis due to the formation of tissue cysts in various organs, such as the brain. Latent toxoplasmosis is probably a risk factor in the development of some neuropsychiatric disorders. Behavioral changes after infection are caused by the host immune response, manipulation by the parasite, central nervous system (CNS) inflammation, as well as changes in hormonal and neuromodulator relationships. The present review focused on the exact mechanisms of T. gondii effect on the alteration of behavior and neurotransmitter levels, their catabolites and metabolites, as well as the interaction between immune responses and this parasite in the etiopathogenesis of psychiatric disorders. The dysfunction of neurotransmitters in the neural transmission is associated with several neuropsychiatric disorders. However, further intensive studies are required to determine the effect of this parasite on altering the level of neurotransmitters and the role of neurotransmitters in the etiology of host behavioral changes.

Keywords: Toxoplasma gondii. Neurotransmitter. Psychiatric disorders. Cytokine.

PubMed Disclaimer

References

    1. Abdoli A, Dalimi A, Arbabi M, Ghaffarifar F (2014) Neuropsychiatric manifestations of latent toxoplasmosis on mothers and their offspring. J Matern-Fetal Neonatal Med 27(13):1368–1374. https://doi.org/10.3109/14767058.2013.858685 - DOI - PubMed
    1. Abedalthagafi M, Rushing EJ, Garvin D, Cheson B, Ozdemirli M (2009) Asymptomatic diffuse "encephalitic" cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia: case report and review of the literature. Int J Clin Exp Pathol 3(1):106–109 - PubMed
    1. Abg Abd Wahab DY, Gau CH, Zakaria R, Muthu Karuppan MK, BS AR, Abdullah Z, Alrafiah A, Abdullah J M, Muthuraju S, (2019) Review on cross talk between neurotransmitters and neuroinflammation in striatum and cerebellum in the mediation of motor behaviour. BioMed Res Int 2019:1767203. https://doi.org/10.1155/2019/1767203 - DOI - PubMed - PMC
    1. Abo-Al-Ela HG (2019) Toxoplasmosis and psychiatric and neurological disorders: a step toward understanding parasite pathogenesis. ACS Chem Neurosci 11(16):2393–2406. https://doi.org/10.1021/acschemneuro.9b00245 - DOI - PubMed
    1. Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol C 153(3):586–600. https://doi.org/10.1152/ajplegacy.1948.153.3.586 - DOI - PubMed

Substances

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /